Bausch Health Companies Inc. (BHC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$5.65
Price Target
$8.00
Target Range
$8.00 — $8.00
Analyst Rating
Buy
Forward P/E1.3x
Trailing P/E13.1x
Forward PEG—
Implied Growth+235.4%
Median Target$8.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$8
+41.6%
Consensus
$8
+41.6%
Bull Case
$8
+41.6%
BHC Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Bausch Health Companies Inc. (BHC) has a Wall Street consensus price target of $8.00, based on estimates from 38 covering analysts. With the stock currently trading at $5.65, this represents a potential upside of +41.6%. The company has a market capitalization of $2.11B.
Analyst price targets range from a low of $8.00 to a high of $8.00, representing a 0% spread in expectations. The median target of $8.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 19 analysts rating the stock as a Buy or Strong Buy,15 rating it Hold, and 4 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BHC trades at a trailing P/E of 13.1x and forward P/E of 1.3x. Analysts expect EPS to grow +235.4% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+29.3%
Avg Forward P/E16.6x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 PBHPrestige Consumer Healthcare Inc. | $2.6B | $54.31 | $66.00 | +21.5% | Buy | 12.0x | 17 |
 PRGOPerrigo Company plc | $1.7B | $12.26 | $20.00 | +63.1% | Hold | 5.8x | 36 |
 BLCOBausch + Lomb Corporation | $5.7B | $16.00 | $19.00 | +18.8% | Hold | 20.2x | 16 |
 COOThe Cooper Companies, Inc. | $12.0B | $61.12 | $93.86 | +53.6% | Buy | 13.2x | 24 |
 ABTAbbott Laboratories | $150.0B | $86.25 | $128.71 | +49.2% | Buy | 15.7x | 41 |
 ALCOAlico, Inc. | $313M | $40.89 | $45.00 | +10.1% | Buy | — | 3 |
 NVSNovartis AG | $283.1B | $148.36 | $141.00 | -5.0% | Hold | 16.9x | 25 |
 EWEdwards Lifesciences Corporation | $48.0B | $83.20 | $96.53 | +16.0% | Buy | 27.7x | 48 |
 MCKMcKesson Corporation | $91.1B | $743.67 | $1006.50 | +35.3% | Buy | 19.1x | 31 |
 CAHCardinal Health, Inc. | $45.1B | $191.49 | $249.67 | +30.4% | Buy | 18.5x | 33 |
Upside Potential Comparison
PRGOCOOABTMCKCAHPBHBLCOEWSee BHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBHC — Frequently Asked Questions
Quick answers to the most common questions about buying BHC stock.
What is the BHC stock price target for 2026?
The consensus Wall Street price target for BHC is $8, representing 41.6% upside from the current price of $5.65. With 38 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is BHC a buy, sell, or hold?
BHC has a consensus rating of "Buy" based on 38 Wall Street analysts. The rating breakdown is mixed, with 15 Hold ratings making up the largest segment. The consensus 12-month price target of $8 implies 41.6% upside from current levels.
Is BHC stock overvalued or undervalued?
With a forward P/E of 1.3074x, BHC trades at a relatively low valuation. The consensus target of $8 implies 41.6% appreciation, suggesting meaningful undervaluation.
How high can BHC stock go?
The most bullish Wall Street analyst has a price target of $8 for BHC, while the most conservative target is $8. The consensus of $8 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover BHC stock?
BHC is heavily covered by Wall Street, with 38 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 19 have Buy ratings, 15 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BHC stock forecast?
The 12-month BHC stock forecast based on 38 Wall Street analysts shows a consensus price target of $8, with estimates ranging from $8 (bear case) to $8 (bull case). The median consensus rating is "Buy".
What is BHC's forward P/E ratio?
BHC trades at a forward P/E ratio of 1.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BHC stock?
Wall Street analysts are very optimistic on BHC, with a "Buy" consensus rating and $8 price target (41.6% upside). 19 of 38 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BHC price targets vary so much?
BHC analyst price targets range from $8 to $8, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $8 consensus represents the middle ground.